Skip to search.
 FTSE 100 Down 0.25%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
7.75 Up 0.45(6.16%) 27 Aug 21:00
Add to Portfolio
Prev Close:7.30
Open:7.40
Bid:7.60 x 700
Ask:8.26 x 100
1y Target Est:23.00
Beta:2.7772
Earnings Date:20 Oct - 26 Oct (Est.)
Day's Range:7.30 - 7.82
52wk Range:6.65 - 19.25
Volume:1,541,209
Avg Vol (3m):960,663
Market Cap:541.42m
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SGMO at this time.

Comparison

Symbol% ChgMkt Cap
SGMOUp 6.16%541.42m
AMGNUp 1.13%118.07b
LLYUp 3.26%88.68b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.36
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.62
Quarterly EPS Est (Sep-15) :-0.18
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focused on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for various monogenic and infectious diseases with ... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback